The Tamper Evident Labeller from LSS Labelling Systems Scandinavia is compliant with the European Falsified Medicines Directive.
Tamper Evident Labeller. Figure courtesy LSS.
The Tamper Evident Labeller from Danish labeling company LSS is in compliance with the European Falsified Medicines Directive (FMD) 2011/62/EU, which includes the requirement for tamper-proof security of cartons. The labeling machine seals the carton, and as an option, a printer and vision system of any brand can be integrated to provide each carton with a unique identification for track and trace and serialization.
The equipment has a capacity of up to 300 cartons per minute. It provides tamper-proof sealing of reverse tuck-end and airplane-closing cartons. The flexible machine handles cartons ranging from 50–220 mm in width, 15–120 mm in height, and 40–120 mm in length. Both transparent and non-transparent labels can be applied. The machine has a small footprint and can be used as an off-line or in-line unit. When entering the machine, each carton’s position and length is registered, and the labeler can stop and restart the process at any position and still maintain a safe product register.
Source: LSS
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.